Literature DB >> 2664196

Bone marrow transplantation: a review.

R E Hardy, E V Ikpeazu.   

Abstract

Bone marrow transplantation represents the technical application of basic immunologic principles to the treatment of a variety of neoplastic and allied disorders that originate in the bone marrow. The results have improved during the past 15 years, being most striking for the treatment of the acute and chronic leukemias. The promise of autologous bone marrow transplantation for the treatment of leukemias and solid tumors is awaiting the perfection of techniques for the effective removal of residual neoplastic cells as well as more effective therapy. The use of this technique at its present stage of development for the treatment of benign hematologic disorders, which cause severe morbidity (ie, thalassemia or sickle cell anemia), is controversial, raises serious ethical issues, and cannot be recommended routinely at this time. Complications of bone marrow transplantation such as graft rejection, graft-versus-host disease, and opportunistic infections are discussed.

Entities:  

Mesh:

Year:  1989        PMID: 2664196      PMCID: PMC2626005     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  69 in total

1.  A randomized study of the prevention of acute graft-versus-host disease.

Authors:  N K Ramsay; J H Kersey; L L Robison; P B McGlave; W G Woods; W Krivit; T H Kim; A I Goldman; M E Nesbit
Journal:  N Engl J Med       Date:  1982-02-18       Impact factor: 91.245

2.  Selective killing of leukaemia cells by antibody-toxin conjugates: implications for autologous bone marrow transplantation.

Authors:  K A Krolick; J W Uhr; E S Vitetta
Journal:  Nature       Date:  1982-02-18       Impact factor: 49.962

Review 3.  Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosis.

Authors:  B M Camitta; R Storb; E D Thomas
Journal:  N Engl J Med       Date:  1982-03-18       Impact factor: 91.245

4.  Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation.

Authors:  P L Weiden; K M Sullivan; N Flournoy; R Storb; E D Thomas
Journal:  N Engl J Med       Date:  1981-06-18       Impact factor: 91.245

5.  Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B.

Authors:  K R Rai; J F Holland; O J Glidewell; V Weinberg; K Brunner; J P Obrecht; H D Preisler; I W Nawabi; D Prager; R W Carey; M R Cooper; F Haurani; J L Hutchison; R T Silver; G Falkson; P Wiernik; H C Hoagland; C D Bloomfield; G W James; A Gottlieb; S V Ramanan; J Blom; N I Nissen; A Bank; R R Ellison; F Kung; P Henry; O R McIntyre; S K Kaan
Journal:  Blood       Date:  1981-12       Impact factor: 22.113

6.  Bone marrow transplantation for refractory acute leukemia in 34 patients with identical twins.

Authors:  A Fefer; M A Cheever; E D Thomas; F R Appelbaum; C D Buckner; R A Clift; H Glucksberg; P D Greenberg; F L Johnson; H G Kaplan; J E Sanders; R Storb; P L Weiden
Journal:  Blood       Date:  1981-03       Impact factor: 22.113

7.  Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment.

Authors:  R Storb; R L Prentice; C D Buckner; R A Clift; F Appelbaum; J Deeg; K Doney; J A Hansen; M Mason; J E Sanders; J Singer; K M Sullivan; R P Witherspoon; E D Thomas
Journal:  N Engl J Med       Date:  1983-02-10       Impact factor: 91.245

8.  Bone marrow transplantation across major histocompatibility barriers in mice. Effect of elimination of T cells from donor grafts by treatment with monoclonal Thy-1.2 plus complement or antibody alone.

Authors:  D A Vallera; C C Soderling; G J Carlson; J H Kersey
Journal:  Transplantation       Date:  1981-03       Impact factor: 4.939

9.  A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission.

Authors:  F L Johnson; E D Thomas; B S Clark; R L Chard; J R Hartmann; R Storb
Journal:  N Engl J Med       Date:  1981-10-08       Impact factor: 91.245

10.  Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells.

Authors:  Y Reisner; N Kapoor; D Kirkpatrick; M S Pollack; S Cunningham-Rundles; B Dupont; M Z Hodes; R A Good; R J O'Reilly
Journal:  Blood       Date:  1983-02       Impact factor: 22.113

View more
  2 in total

Review 1.  Cellular transplantation and gene therapy.

Authors:  C Ricordi; S T Ildstad; T E Starzl
Journal:  Clin Transplant       Date:  1993-02       Impact factor: 2.863

2.  DNA profiling in peripheral blood, buccal swabs, hair follicles and semen from a patient following allogeneic hematopoietic stem cells transplantation.

Authors:  Ya-Ting Li; Ming-Kun Xie; Jin Wu
Journal:  Biomed Rep       Date:  2014-08-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.